nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—FMO3—sweat—pancreatitis	0.0274	0.114	CbGeAlD
Dasatinib—Left ventricular failure—Hyoscyamine—pancreatitis	0.0224	0.0915	CcSEcCtD
Dasatinib—Temperature intolerance—Hyoscyamine—pancreatitis	0.0224	0.0915	CcSEcCtD
Dasatinib—Oral disorder—Hyoscyamine—pancreatitis	0.0146	0.0595	CcSEcCtD
Dasatinib—Rash papular—Hyoscyamine—pancreatitis	0.00988	0.0403	CcSEcCtD
Dasatinib—Rash macular—Hyoscyamine—pancreatitis	0.00897	0.0366	CcSEcCtD
Dasatinib—SRMS—gall bladder—pancreatitis	0.00797	0.0332	CbGeAlD
Dasatinib—Visual acuity reduced—Hyoscyamine—pancreatitis	0.00619	0.0253	CcSEcCtD
Dasatinib—Electrocardiogram QT prolonged—Hyoscyamine—pancreatitis	0.00574	0.0234	CcSEcCtD
Dasatinib—ERBB3—exocrine gland—pancreatitis	0.00528	0.022	CbGeAlD
Dasatinib—Ventricular arrhythmia—Hyoscyamine—pancreatitis	0.00497	0.0203	CcSEcCtD
Dasatinib—STAT5B—islet of Langerhans—pancreatitis	0.00484	0.0201	CbGeAlD
Dasatinib—Rash erythematous—Hyoscyamine—pancreatitis	0.00481	0.0196	CcSEcCtD
Dasatinib—TEC—blood—pancreatitis	0.00474	0.0197	CbGeAlD
Dasatinib—Abdominal distension—Propantheline—pancreatitis	0.00454	0.0185	CcSEcCtD
Dasatinib—Dysphagia—Propantheline—pancreatitis	0.00451	0.0184	CcSEcCtD
Dasatinib—Petechiae—Hyoscyamine—pancreatitis	0.00448	0.0183	CcSEcCtD
Dasatinib—Ventricular tachycardia—Hyoscyamine—pancreatitis	0.00368	0.015	CcSEcCtD
Dasatinib—TESK1—islet of Langerhans—pancreatitis	0.00358	0.0149	CbGeAlD
Dasatinib—Skin exfoliation—Hyoscyamine—pancreatitis	0.00352	0.0143	CcSEcCtD
Dasatinib—STAT5B—pancreas—pancreatitis	0.0034	0.0142	CbGeAlD
Dasatinib—Dry eye—Hyoscyamine—pancreatitis	0.0034	0.0139	CcSEcCtD
Dasatinib—PDGFRA—gall bladder—pancreatitis	0.0034	0.0141	CbGeAlD
Dasatinib—Flushing—Propantheline—pancreatitis	0.00335	0.0137	CcSEcCtD
Dasatinib—Rash maculo-papular—Hyoscyamine—pancreatitis	0.00335	0.0137	CcSEcCtD
Dasatinib—STK35—islet of Langerhans—pancreatitis	0.0033	0.0137	CbGeAlD
Dasatinib—Pulmonary oedema—Hyoscyamine—pancreatitis	0.00328	0.0134	CcSEcCtD
Dasatinib—CSK—islet of Langerhans—pancreatitis	0.00328	0.0136	CbGeAlD
Dasatinib—KIT—exocrine gland—pancreatitis	0.00323	0.0134	CbGeAlD
Dasatinib—EPHB2—digestive system—pancreatitis	0.0032	0.0133	CbGeAlD
Dasatinib—PKMYT1—blood—pancreatitis	0.0032	0.0133	CbGeAlD
Dasatinib—SRMS—digestive system—pancreatitis	0.00314	0.013	CbGeAlD
Dasatinib—BMX—blood—pancreatitis	0.00312	0.013	CbGeAlD
Dasatinib—BLK—blood—pancreatitis	0.00309	0.0128	CbGeAlD
Dasatinib—PTK6—digestive system—pancreatitis	0.00307	0.0128	CbGeAlD
Dasatinib—RIPK2—islet of Langerhans—pancreatitis	0.00304	0.0127	CbGeAlD
Dasatinib—Eczema—Hyoscyamine—pancreatitis	0.00297	0.0121	CcSEcCtD
Dasatinib—SIK1—islet of Langerhans—pancreatitis	0.00297	0.0124	CbGeAlD
Dasatinib—Vision blurred—Propantheline—pancreatitis	0.00296	0.0121	CcSEcCtD
Dasatinib—TXK—blood—pancreatitis	0.00296	0.0123	CbGeAlD
Dasatinib—PTK6—blood—pancreatitis	0.00293	0.0122	CbGeAlD
Dasatinib—STAT5B—digestive system—pancreatitis	0.00291	0.0121	CbGeAlD
Dasatinib—Amnesia—Hyoscyamine—pancreatitis	0.00284	0.0116	CcSEcCtD
Dasatinib—Atrial fibrillation—Hyoscyamine—pancreatitis	0.00282	0.0115	CcSEcCtD
Dasatinib—Palpitations—Propantheline—pancreatitis	0.00278	0.0113	CcSEcCtD
Dasatinib—STAT5B—blood—pancreatitis	0.00277	0.0115	CbGeAlD
Dasatinib—KIT—gall bladder—pancreatitis	0.00272	0.0113	CbGeAlD
Dasatinib—PDGFRB—gall bladder—pancreatitis	0.00265	0.011	CbGeAlD
Dasatinib—Confusional state—Propantheline—pancreatitis	0.00259	0.0106	CcSEcCtD
Dasatinib—EPHB4—islet of Langerhans—pancreatitis	0.00257	0.0107	CbGeAlD
Dasatinib—EPHA2—islet of Langerhans—pancreatitis	0.00252	0.0105	CbGeAlD
Dasatinib—Tachycardia—Propantheline—pancreatitis	0.0025	0.0102	CcSEcCtD
Dasatinib—MAP4K5—islet of Langerhans—pancreatitis	0.00246	0.0102	CbGeAlD
Dasatinib—Dry skin—Hyoscyamine—pancreatitis	0.00245	0.00999	CcSEcCtD
Dasatinib—Hypokalaemia—Hyoscyamine—pancreatitis	0.00243	0.00992	CcSEcCtD
Dasatinib—ZAK—digestive system—pancreatitis	0.00243	0.0101	CbGeAlD
Dasatinib—EPHA5—digestive system—pancreatitis	0.00238	0.00989	CbGeAlD
Dasatinib—EPHB6—islet of Langerhans—pancreatitis	0.00235	0.00978	CbGeAlD
Dasatinib—Abdominal distension—Hyoscyamine—pancreatitis	0.00233	0.00949	CcSEcCtD
Dasatinib—Insomnia—Propantheline—pancreatitis	0.00232	0.00947	CcSEcCtD
Dasatinib—STK35—pancreas—pancreatitis	0.00232	0.00965	CbGeAlD
Dasatinib—ZAK—blood—pancreatitis	0.00231	0.00963	CbGeAlD
Dasatinib—Dysphagia—Hyoscyamine—pancreatitis	0.00231	0.00942	CcSEcCtD
Dasatinib—CSK—pancreas—pancreatitis	0.0023	0.00958	CbGeAlD
Dasatinib—Somnolence—Propantheline—pancreatitis	0.00228	0.00931	CcSEcCtD
Dasatinib—YES1—islet of Langerhans—pancreatitis	0.00227	0.00945	CbGeAlD
Dasatinib—LYN—blood—pancreatitis	0.00225	0.00937	CbGeAlD
Dasatinib—Angina pectoris—Hyoscyamine—pancreatitis	0.00225	0.00918	CcSEcCtD
Dasatinib—BTK—blood—pancreatitis	0.00221	0.00918	CbGeAlD
Dasatinib—Constipation—Propantheline—pancreatitis	0.00219	0.00895	CcSEcCtD
Dasatinib—SRC—islet of Langerhans—pancreatitis	0.00218	0.00909	CbGeAlD
Dasatinib—Feeling abnormal—Propantheline—pancreatitis	0.00211	0.00863	CcSEcCtD
Dasatinib—EPHB3—digestive system—pancreatitis	0.00211	0.00879	CbGeAlD
Dasatinib—SIK1—pancreas—pancreatitis	0.00209	0.00868	CbGeAlD
Dasatinib—ERBB3—pancreas—pancreatitis	0.00205	0.00851	CbGeAlD
Dasatinib—TESK1—blood—pancreatitis	0.00205	0.00851	CbGeAlD
Dasatinib—Urticaria—Propantheline—pancreatitis	0.00204	0.00832	CcSEcCtD
Dasatinib—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.00203	0.00828	CcSEcCtD
Dasatinib—Myocardial infarction—Hyoscyamine—pancreatitis	0.00202	0.00824	CcSEcCtD
Dasatinib—STK36—blood—pancreatitis	0.00201	0.00837	CbGeAlD
Dasatinib—Conjunctivitis—Hyoscyamine—pancreatitis	0.002	0.00817	CcSEcCtD
Dasatinib—CSK—digestive system—pancreatitis	0.00197	0.00818	CbGeAlD
Dasatinib—LIMK2—blood—pancreatitis	0.00195	0.0081	CbGeAlD
Dasatinib—HCK—digestive system—pancreatitis	0.00194	0.00808	CbGeAlD
Dasatinib—Hypersensitivity—Propantheline—pancreatitis	0.00189	0.00771	CcSEcCtD
Dasatinib—CSK—blood—pancreatitis	0.00187	0.0078	CbGeAlD
Dasatinib—HCK—blood—pancreatitis	0.00185	0.0077	CbGeAlD
Dasatinib—Asthenia—Propantheline—pancreatitis	0.00184	0.00751	CcSEcCtD
Dasatinib—ABL2—blood—pancreatitis	0.00184	0.00765	CbGeAlD
Dasatinib—RIPK2—digestive system—pancreatitis	0.00183	0.0076	CbGeAlD
Dasatinib—EPHB4—pancreas—pancreatitis	0.00181	0.00751	CbGeAlD
Dasatinib—EPHA2—pancreas—pancreatitis	0.00177	0.00737	CbGeAlD
Dasatinib—ERBB3—digestive system—pancreatitis	0.00175	0.00727	CbGeAlD
Dasatinib—PDGFRB—islet of Langerhans—pancreatitis	0.00174	0.00724	CbGeAlD
Dasatinib—RIPK2—blood—pancreatitis	0.00174	0.00724	CbGeAlD
Dasatinib—MAP4K5—pancreas—pancreatitis	0.00173	0.00719	CbGeAlD
Dasatinib—Flushing—Hyoscyamine—pancreatitis	0.00172	0.007	CcSEcCtD
Dasatinib—SIK1—blood—pancreatitis	0.0017	0.00707	CbGeAlD
Dasatinib—Dizziness—Propantheline—pancreatitis	0.0017	0.00692	CcSEcCtD
Dasatinib—EPHA4—blood—pancreatitis	0.00168	0.00699	CbGeAlD
Dasatinib—Arrhythmia—Hyoscyamine—pancreatitis	0.00165	0.00674	CcSEcCtD
Dasatinib—MAP3K2—blood—pancreatitis	0.00165	0.00686	CbGeAlD
Dasatinib—Vomiting—Propantheline—pancreatitis	0.00163	0.00666	CcSEcCtD
Dasatinib—MAPK14—digestive system—pancreatitis	0.00163	0.00677	CbGeAlD
Dasatinib—FGR—digestive system—pancreatitis	0.00162	0.00674	CbGeAlD
Dasatinib—Mental disorder—Hyoscyamine—pancreatitis	0.00162	0.00661	CcSEcCtD
Dasatinib—Rash—Propantheline—pancreatitis	0.00162	0.0066	CcSEcCtD
Dasatinib—Dermatitis—Propantheline—pancreatitis	0.00162	0.00659	CcSEcCtD
Dasatinib—Erythema—Hyoscyamine—pancreatitis	0.00161	0.00657	CcSEcCtD
Dasatinib—Headache—Propantheline—pancreatitis	0.00161	0.00656	CcSEcCtD
Dasatinib—YES1—pancreas—pancreatitis	0.0016	0.00664	CbGeAlD
Dasatinib—Dysgeusia—Hyoscyamine—pancreatitis	0.00158	0.00643	CcSEcCtD
Dasatinib—ABL1—islet of Langerhans—pancreatitis	0.00155	0.00645	CbGeAlD
Dasatinib—MAPK14—blood—pancreatitis	0.00155	0.00645	CbGeAlD
Dasatinib—FGR—blood—pancreatitis	0.00154	0.00642	CbGeAlD
Dasatinib—LCK—blood—pancreatitis	0.00154	0.00642	CbGeAlD
Dasatinib—EPHB4—digestive system—pancreatitis	0.00154	0.00642	CbGeAlD
Dasatinib—SRC—pancreas—pancreatitis	0.00154	0.00639	CbGeAlD
Dasatinib—JAK2—digestive system—pancreatitis	0.00153	0.00637	CbGeAlD
Dasatinib—Nausea—Propantheline—pancreatitis	0.00152	0.00622	CcSEcCtD
Dasatinib—Vision blurred—Hyoscyamine—pancreatitis	0.00152	0.00619	CcSEcCtD
Dasatinib—EPHA2—digestive system—pancreatitis	0.00151	0.0063	CbGeAlD
Dasatinib—FYN—digestive system—pancreatitis	0.00151	0.00629	CbGeAlD
Dasatinib—EPHB4—blood—pancreatitis	0.00147	0.00611	CbGeAlD
Dasatinib—JAK2—blood—pancreatitis	0.00146	0.00607	CbGeAlD
Dasatinib—Vertigo—Hyoscyamine—pancreatitis	0.00145	0.0059	CcSEcCtD
Dasatinib—Syncope—Hyoscyamine—pancreatitis	0.00144	0.00589	CcSEcCtD
Dasatinib—EPHA2—blood—pancreatitis	0.00144	0.006	CbGeAlD
Dasatinib—FYN—blood—pancreatitis	0.00144	0.00599	CbGeAlD
Dasatinib—Palpitations—Hyoscyamine—pancreatitis	0.00142	0.0058	CcSEcCtD
Dasatinib—Loss of consciousness—Hyoscyamine—pancreatitis	0.00141	0.00577	CcSEcCtD
Dasatinib—MAP3K3—blood—pancreatitis	0.00141	0.00585	CbGeAlD
Dasatinib—MAP4K5—blood—pancreatitis	0.00141	0.00585	CbGeAlD
Dasatinib—Convulsion—Hyoscyamine—pancreatitis	0.00139	0.00569	CcSEcCtD
Dasatinib—Chest pain—Hyoscyamine—pancreatitis	0.00137	0.00559	CcSEcCtD
Dasatinib—Anxiety—Hyoscyamine—pancreatitis	0.00137	0.00557	CcSEcCtD
Dasatinib—YES1—digestive system—pancreatitis	0.00136	0.00567	CbGeAlD
Dasatinib—EPHB6—blood—pancreatitis	0.00134	0.00559	CbGeAlD
Dasatinib—PDGFRA—digestive system—pancreatitis	0.00134	0.00556	CbGeAlD
Dasatinib—Confusional state—Hyoscyamine—pancreatitis	0.00132	0.0054	CcSEcCtD
Dasatinib—Oedema—Hyoscyamine—pancreatitis	0.00131	0.00536	CcSEcCtD
Dasatinib—SRC—digestive system—pancreatitis	0.00131	0.00546	CbGeAlD
Dasatinib—YES1—blood—pancreatitis	0.0013	0.0054	CbGeAlD
Dasatinib—Shock—Hyoscyamine—pancreatitis	0.00129	0.00527	CcSEcCtD
Dasatinib—Tachycardia—Hyoscyamine—pancreatitis	0.00128	0.00523	CcSEcCtD
Dasatinib—PDGFRA—blood—pancreatitis	0.00127	0.0053	CbGeAlD
Dasatinib—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00127	0.00518	CcSEcCtD
Dasatinib—KIT—pancreas—pancreatitis	0.00125	0.00521	CbGeAlD
Dasatinib—SRC—blood—pancreatitis	0.00125	0.0052	CbGeAlD
Dasatinib—Hypotension—Hyoscyamine—pancreatitis	0.00123	0.00501	CcSEcCtD
Dasatinib—PDGFRB—pancreas—pancreatitis	0.00122	0.00509	CbGeAlD
Dasatinib—Insomnia—Hyoscyamine—pancreatitis	0.00119	0.00485	CcSEcCtD
Dasatinib—CSF1R—digestive system—pancreatitis	0.00118	0.0049	CbGeAlD
Dasatinib—Dyspnoea—Hyoscyamine—pancreatitis	0.00117	0.00478	CcSEcCtD
Dasatinib—Somnolence—Hyoscyamine—pancreatitis	0.00117	0.00476	CcSEcCtD
Dasatinib—Dyspepsia—Hyoscyamine—pancreatitis	0.00116	0.00472	CcSEcCtD
Dasatinib—MAP2K5—blood—pancreatitis	0.00115	0.00478	CbGeAlD
Dasatinib—Fatigue—Hyoscyamine—pancreatitis	0.00113	0.00462	CcSEcCtD
Dasatinib—Pain—Hyoscyamine—pancreatitis	0.00112	0.00458	CcSEcCtD
Dasatinib—Constipation—Hyoscyamine—pancreatitis	0.00112	0.00458	CcSEcCtD
Dasatinib—CSF1R—blood—pancreatitis	0.00112	0.00467	CbGeAlD
Dasatinib—ABL1—pancreas—pancreatitis	0.00109	0.00453	CbGeAlD
Dasatinib—Feeling abnormal—Hyoscyamine—pancreatitis	0.00108	0.00442	CcSEcCtD
Dasatinib—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00107	0.00438	CcSEcCtD
Dasatinib—KIT—digestive system—pancreatitis	0.00107	0.00445	CbGeAlD
Dasatinib—PDGFRB—digestive system—pancreatitis	0.00104	0.00434	CbGeAlD
Dasatinib—Urticaria—Hyoscyamine—pancreatitis	0.00104	0.00426	CcSEcCtD
Dasatinib—Abdominal pain—Hyoscyamine—pancreatitis	0.00104	0.00424	CcSEcCtD
Dasatinib—Body temperature increased—Hyoscyamine—pancreatitis	0.00104	0.00424	CcSEcCtD
Dasatinib—KIT—blood—pancreatitis	0.00102	0.00424	CbGeAlD
Dasatinib—PDGFRB—blood—pancreatitis	0.000995	0.00414	CbGeAlD
Dasatinib—Hypersensitivity—Hyoscyamine—pancreatitis	0.000968	0.00395	CcSEcCtD
Dasatinib—Asthenia—Hyoscyamine—pancreatitis	0.000942	0.00384	CcSEcCtD
Dasatinib—ABL1—digestive system—pancreatitis	0.000931	0.00387	CbGeAlD
Dasatinib—Pruritus—Hyoscyamine—pancreatitis	0.000929	0.00379	CcSEcCtD
Dasatinib—CYP3A5—islet of Langerhans—pancreatitis	0.000907	0.00378	CbGeAlD
Dasatinib—Diarrhoea—Hyoscyamine—pancreatitis	0.000899	0.00367	CcSEcCtD
Dasatinib—ABL1—blood—pancreatitis	0.000887	0.00369	CbGeAlD
Dasatinib—Dizziness—Hyoscyamine—pancreatitis	0.000869	0.00354	CcSEcCtD
Dasatinib—Vomiting—Hyoscyamine—pancreatitis	0.000835	0.00341	CcSEcCtD
Dasatinib—Rash—Hyoscyamine—pancreatitis	0.000828	0.00338	CcSEcCtD
Dasatinib—Dermatitis—Hyoscyamine—pancreatitis	0.000827	0.00338	CcSEcCtD
Dasatinib—Headache—Hyoscyamine—pancreatitis	0.000823	0.00336	CcSEcCtD
Dasatinib—CYP1B1—digestive system—pancreatitis	0.000788	0.00328	CbGeAlD
Dasatinib—Nausea—Hyoscyamine—pancreatitis	0.00078	0.00318	CcSEcCtD
Dasatinib—CYP1B1—blood—pancreatitis	0.000751	0.00312	CbGeAlD
Dasatinib—CYP3A5—pancreas—pancreatitis	0.000638	0.00265	CbGeAlD
Dasatinib—CYP1A2—digestive system—pancreatitis	0.000565	0.00235	CbGeAlD
Dasatinib—ABCG2—blood—pancreatitis	0.000559	0.00233	CbGeAlD
Dasatinib—CYP1A1—digestive system—pancreatitis	0.000557	0.00232	CbGeAlD
Dasatinib—CYP3A5—digestive system—pancreatitis	0.000545	0.00227	CbGeAlD
Dasatinib—CYP1A2—blood—pancreatitis	0.000538	0.00224	CbGeAlD
Dasatinib—CYP1A1—blood—pancreatitis	0.000531	0.00221	CbGeAlD
Dasatinib—CYP3A5—blood—pancreatitis	0.000519	0.00216	CbGeAlD
Dasatinib—ABCB1—islet of Langerhans—pancreatitis	0.000482	0.00201	CbGeAlD
Dasatinib—CYP3A4—digestive system—pancreatitis	0.000409	0.0017	CbGeAlD
Dasatinib—CYP3A4—blood—pancreatitis	0.000389	0.00162	CbGeAlD
Dasatinib—ABCB1—pancreas—pancreatitis	0.000339	0.00141	CbGeAlD
Dasatinib—ABCB1—digestive system—pancreatitis	0.000289	0.0012	CbGeAlD
Dasatinib—ABCB1—blood—pancreatitis	0.000276	0.00115	CbGeAlD
Dasatinib—STAT5B—Signaling Pathways—IL6—pancreatitis	7.12e-06	1.38e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—LPL—pancreatitis	7.11e-06	1.38e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NRAS—pancreatitis	7.09e-06	1.38e-05	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	7.05e-06	1.37e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TGFB1—pancreatitis	7.05e-06	1.37e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CCL2—pancreatitis	7.05e-06	1.37e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—INS—pancreatitis	7.02e-06	1.36e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CASP3—pancreatitis	7.01e-06	1.36e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MDM2—pancreatitis	6.99e-06	1.36e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—HRAS—pancreatitis	6.99e-06	1.36e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—HRAS—pancreatitis	6.99e-06	1.36e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—KRAS—pancreatitis	6.98e-06	1.36e-05	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—KRAS—pancreatitis	6.97e-06	1.36e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—HRAS—pancreatitis	6.97e-06	1.36e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—TGFB1—pancreatitis	6.96e-06	1.35e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—NRAS—pancreatitis	6.94e-06	1.35e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—NRAS—pancreatitis	6.94e-06	1.35e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—NRAS—pancreatitis	6.92e-06	1.34e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—INS—pancreatitis	6.91e-06	1.34e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCL2—pancreatitis	6.9e-06	1.34e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—HRAS—pancreatitis	6.86e-06	1.33e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—MDM2—pancreatitis	6.83e-06	1.33e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCL2—pancreatitis	6.8e-06	1.32e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PPARG—pancreatitis	6.79e-06	1.32e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—NRAS—pancreatitis	6.77e-06	1.32e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALDH2—pancreatitis	6.75e-06	1.31e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—NRAS—pancreatitis	6.74e-06	1.31e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SPP1—pancreatitis	6.73e-06	1.31e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—LEP—pancreatitis	6.73e-06	1.31e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—ALB—pancreatitis	6.71e-06	1.3e-05	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—HRAS—pancreatitis	6.7e-06	1.3e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—NRAS—pancreatitis	6.69e-06	1.3e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—IL6—pancreatitis	6.69e-06	1.3e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—IL6—pancreatitis	6.69e-06	1.3e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—IL6—pancreatitis	6.67e-06	1.3e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—NRAS—pancreatitis	6.67e-06	1.3e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—LPL—pancreatitis	6.67e-06	1.3e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—INS—pancreatitis	6.66e-06	1.29e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—INS—pancreatitis	6.65e-06	1.29e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—HRAS—pancreatitis	6.64e-06	1.29e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1B—pancreatitis	6.64e-06	1.29e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MDM2—pancreatitis	6.62e-06	1.29e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—KRAS—pancreatitis	6.61e-06	1.28e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—TGFB1—pancreatitis	6.59e-06	1.28e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—PTGS2—pancreatitis	6.59e-06	1.28e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	6.58e-06	1.28e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—INS—pancreatitis	6.57e-06	1.28e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—MDM2—pancreatitis	6.55e-06	1.27e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCL2—pancreatitis	6.54e-06	1.27e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CXCL8—pancreatitis	6.54e-06	1.27e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—KRAS—pancreatitis	6.53e-06	1.27e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCL2—pancreatitis	6.46e-06	1.26e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TGFB1—pancreatitis	6.45e-06	1.25e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—KRAS—pancreatitis	6.45e-06	1.25e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—NRAS—pancreatitis	6.42e-06	1.25e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GCG—pancreatitis	6.41e-06	1.25e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR2A—pancreatitis	6.41e-06	1.25e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NRAS—pancreatitis	6.39e-06	1.24e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—pancreatitis	6.36e-06	1.24e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—NRAS—pancreatitis	6.34e-06	1.23e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—LPL—pancreatitis	6.3e-06	1.22e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CASP3—pancreatitis	6.26e-06	1.22e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TGFB1—pancreatitis	6.22e-06	1.21e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CXCL8—pancreatitis	6.19e-06	1.2e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—HRAS—pancreatitis	6.17e-06	1.2e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—NRAS—pancreatitis	6.16e-06	1.2e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ALB—pancreatitis	6.11e-06	1.19e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—KRAS—pancreatitis	6.1e-06	1.19e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—MDM2—pancreatitis	6.05e-06	1.18e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—KRAS—pancreatitis	5.97e-06	1.16e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—KRAS—pancreatitis	5.97e-06	1.16e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MDM2—pancreatitis	5.96e-06	1.16e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—LEP—pancreatitis	5.96e-06	1.16e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—KRAS—pancreatitis	5.95e-06	1.16e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—TGFB1—pancreatitis	5.93e-06	1.15e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—HRAS—pancreatitis	5.93e-06	1.15e-05	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—HRAS—pancreatitis	5.93e-06	1.15e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CASP3—pancreatitis	5.92e-06	1.15e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	5.92e-06	1.15e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—pancreatitis	5.91e-06	1.15e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PLA2G1B—pancreatitis	5.9e-06	1.15e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1B—pancreatitis	5.88e-06	1.14e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTGS2—pancreatitis	5.87e-06	1.14e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—NRAS—pancreatitis	5.87e-06	1.14e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—NRAS—pancreatitis	5.85e-06	1.14e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MDM2—pancreatitis	5.84e-06	1.13e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—PTGS2—pancreatitis	5.83e-06	1.13e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—KRAS—pancreatitis	5.83e-06	1.13e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—KRAS—pancreatitis	5.8e-06	1.13e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—KRAS—pancreatitis	5.76e-06	1.12e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—INS—pancreatitis	5.75e-06	1.12e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MDM2—pancreatitis	5.75e-06	1.12e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—KRAS—pancreatitis	5.74e-06	1.12e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—TGFB1—pancreatitis	5.72e-06	1.11e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—A2M—pancreatitis	5.7e-06	1.11e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—pancreatitis	5.68e-06	1.1e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCL2—pancreatitis	5.66e-06	1.1e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HRAS—pancreatitis	5.62e-06	1.09e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CXCL8—pancreatitis	5.57e-06	1.08e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—HRAS—pancreatitis	5.55e-06	1.08e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—NRAS—pancreatitis	5.55e-06	1.08e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MDM2—pancreatitis	5.53e-06	1.08e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—KRAS—pancreatitis	5.53e-06	1.07e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—KRAS—pancreatitis	5.5e-06	1.07e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—HRAS—pancreatitis	5.48e-06	1.06e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MDM2—pancreatitis	5.46e-06	1.06e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CXCL8—pancreatitis	5.46e-06	1.06e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TGFB1—pancreatitis	5.46e-06	1.06e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—KRAS—pancreatitis	5.45e-06	1.06e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—TGFB1—pancreatitis	5.44e-06	1.06e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—pancreatitis	5.38e-06	1.04e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CXCL8—pancreatitis	5.37e-06	1.04e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTGS2—pancreatitis	5.34e-06	1.04e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CASP3—pancreatitis	5.34e-06	1.04e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—pancreatitis	5.31e-06	1.03e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—KRAS—pancreatitis	5.3e-06	1.03e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NRAS—pancreatitis	5.24e-06	1.02e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—pancreatitis	5.24e-06	1.02e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CASP3—pancreatitis	5.22e-06	1.02e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALDH2—pancreatitis	5.21e-06	1.01e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—HRAS—pancreatitis	5.19e-06	1.01e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	5.18e-06	1.01e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CXCL8—pancreatitis	5.17e-06	1.01e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CASP3—pancreatitis	5.14e-06	1e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—NRAS—pancreatitis	5.13e-06	9.96e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GCG—pancreatitis	5.12e-06	9.95e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CXCL8—pancreatitis	5.11e-06	9.93e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—INS—pancreatitis	5.09e-06	9.89e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—HRAS—pancreatitis	5.08e-06	9.87e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—HRAS—pancreatitis	5.07e-06	9.86e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HRAS—pancreatitis	5.06e-06	9.83e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—KRAS—pancreatitis	5.05e-06	9.82e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—KRAS—pancreatitis	5.04e-06	9.79e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—LPL—pancreatitis	5.03e-06	9.78e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL2—pancreatitis	5.01e-06	9.74e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NRAS—pancreatitis	4.96e-06	9.65e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—pancreatitis	4.96e-06	9.65e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—HRAS—pancreatitis	4.95e-06	9.63e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CASP3—pancreatitis	4.95e-06	9.62e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HRAS—pancreatitis	4.93e-06	9.58e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—NRAS—pancreatitis	4.91e-06	9.55e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—HRAS—pancreatitis	4.89e-06	9.51e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CASP3—pancreatitis	4.89e-06	9.5e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—HRAS—pancreatitis	4.88e-06	9.48e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—pancreatitis	4.87e-06	9.47e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARG—pancreatitis	4.87e-06	9.46e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—pancreatitis	4.86e-06	9.44e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—pancreatitis	4.86e-06	9.44e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—pancreatitis	4.84e-06	9.41e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MDM2—pancreatitis	4.78e-06	9.3e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—KRAS—pancreatitis	4.78e-06	9.29e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—INS—pancreatitis	4.77e-06	9.28e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—pancreatitis	4.76e-06	9.26e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—pancreatitis	4.74e-06	9.22e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—pancreatitis	4.72e-06	9.17e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HRAS—pancreatitis	4.7e-06	9.13e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—pancreatitis	4.68e-06	9.1e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—HRAS—pancreatitis	4.67e-06	9.08e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—pancreatitis	4.67e-06	9.07e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HRAS—pancreatitis	4.64e-06	9.01e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—pancreatitis	4.61e-06	8.96e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARG—pancreatitis	4.6e-06	8.94e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—NRAS—pancreatitis	4.54e-06	8.82e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—KRAS—pancreatitis	4.51e-06	8.77e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—INS—pancreatitis	4.51e-06	8.77e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—HRAS—pancreatitis	4.5e-06	8.75e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—pancreatitis	4.5e-06	8.74e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CXCL8—pancreatitis	4.47e-06	8.69e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NRAS—pancreatitis	4.47e-06	8.69e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—pancreatitis	4.47e-06	8.69e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—pancreatitis	4.44e-06	8.62e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—KRAS—pancreatitis	4.41e-06	8.57e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NRAS—pancreatitis	4.38e-06	8.51e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—pancreatitis	4.38e-06	8.51e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NRAS—pancreatitis	4.31e-06	8.38e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—pancreatitis	4.31e-06	8.38e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—HRAS—pancreatitis	4.3e-06	8.35e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CASP3—pancreatitis	4.28e-06	8.32e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—HRAS—pancreatitis	4.28e-06	8.32e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—KRAS—pancreatitis	4.27e-06	8.3e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MDM2—pancreatitis	4.24e-06	8.23e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—KRAS—pancreatitis	4.23e-06	8.22e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—pancreatitis	4.22e-06	8.19e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—pancreatitis	4.16e-06	8.08e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NRAS—pancreatitis	4.15e-06	8.07e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—pancreatitis	4.13e-06	8.04e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—pancreatitis	4.11e-06	7.99e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NRAS—pancreatitis	4.1e-06	7.96e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—pancreatitis	4.1e-06	7.96e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—pancreatitis	4.07e-06	7.91e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—HRAS—pancreatitis	4.06e-06	7.89e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—LPL—pancreatitis	4.02e-06	7.8e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—pancreatitis	4.01e-06	7.78e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CXCL8—pancreatitis	3.96e-06	7.7e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GCG—pancreatitis	3.95e-06	7.68e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—KRAS—pancreatitis	3.91e-06	7.59e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—pancreatitis	3.89e-06	7.55e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—pancreatitis	3.86e-06	7.5e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—KRAS—pancreatitis	3.85e-06	7.48e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—HRAS—pancreatitis	3.84e-06	7.46e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—pancreatitis	3.83e-06	7.44e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—pancreatitis	3.81e-06	7.4e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CASP3—pancreatitis	3.79e-06	7.37e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—KRAS—pancreatitis	3.77e-06	7.32e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—HRAS—pancreatitis	3.75e-06	7.29e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—KRAS—pancreatitis	3.71e-06	7.21e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARG—pancreatitis	3.67e-06	7.14e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—pancreatitis	3.67e-06	7.14e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—HRAS—pancreatitis	3.63e-06	7.06e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—pancreatitis	3.62e-06	7.03e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—INS—pancreatitis	3.6e-06	7e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—HRAS—pancreatitis	3.6e-06	6.99e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NRAS—pancreatitis	3.59e-06	6.98e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—pancreatitis	3.59e-06	6.97e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—KRAS—pancreatitis	3.57e-06	6.94e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—KRAS—pancreatitis	3.53e-06	6.85e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—pancreatitis	3.48e-06	6.76e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—pancreatitis	3.44e-06	6.69e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—pancreatitis	3.33e-06	6.48e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—HRAS—pancreatitis	3.32e-06	6.45e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—pancreatitis	3.3e-06	6.42e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—HRAS—pancreatitis	3.27e-06	6.36e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—HRAS—pancreatitis	3.2e-06	6.23e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NRAS—pancreatitis	3.18e-06	6.17e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—pancreatitis	3.18e-06	6.17e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—HRAS—pancreatitis	3.15e-06	6.13e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—pancreatitis	3.13e-06	6.09e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—LPL—pancreatitis	3.1e-06	6.02e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—KRAS—pancreatitis	3.09e-06	6e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—pancreatitis	3.07e-06	5.96e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—HRAS—pancreatitis	3.04e-06	5.9e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—pancreatitis	3.02e-06	5.87e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—HRAS—pancreatitis	3e-06	5.83e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—pancreatitis	2.95e-06	5.74e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARG—pancreatitis	2.93e-06	5.7e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—pancreatitis	2.91e-06	5.65e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—pancreatitis	2.89e-06	5.62e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—INS—pancreatitis	2.88e-06	5.59e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—pancreatitis	2.87e-06	5.58e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—KRAS—pancreatitis	2.73e-06	5.31e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—pancreatitis	2.64e-06	5.12e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HRAS—pancreatitis	2.63e-06	5.1e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—pancreatitis	2.51e-06	4.88e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HRAS—pancreatitis	2.32e-06	4.52e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—pancreatitis	2.31e-06	4.48e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARG—pancreatitis	2.26e-06	4.4e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—pancreatitis	2.22e-06	4.32e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—INS—pancreatitis	2.22e-06	4.31e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—pancreatitis	2.03e-06	3.95e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—pancreatitis	1.78e-06	3.46e-06	CbGpPWpGaD
